Dilip Shanghvi

Indian Businessman

Dilip Shanghvi was born in Mumbai, Maharashtra, India on October 1st, 1955 and is the Indian Businessman. At the age of 69, Dilip Shanghvi biography, profession, age, height, weight, eye color, hair color, build, measurements, education, career, dating/affair, family, news updates, and networth are available.

  Report
Other Names / Nick Names
Dilip
Date of Birth
October 1, 1955
Nationality
India
Place of Birth
Mumbai, Maharashtra, India
Age
69 years old
Zodiac Sign
Libra
Profession
Chief Executive Officer, Entrepreneur
Dilip Shanghvi Height, Weight, Eye Color and Hair Color

At 69 years old, Dilip Shanghvi has this physical status:

Height
170cm
Weight
70kg
Hair Color
Salt and Pepper
Eye Color
Dark Brown
Build
Average
Measurements
Not Available
Dilip Shanghvi Religion, Education, and Hobbies
Religion
Not Available
Hobbies
Not Available
Education
J. J. Ajmera High School, The Bhawanipur Gujarati Education Society School, Bhawanipur Education Society College, University of Calcutta
Dilip Shanghvi Spouse(s), Children, Affair, Parents, and Family
Spouse(s)
Vibha Shanghvi
Children
2
Dating / Affair
Vibha Shanghvi
Parents
Shantilal Shanghvi, Kumud Shanghvi
Dilip Shanghvi Career

Shanghvi started by helping his father in his business, which was a wholesale dealership of medicines, mainly generic drugs, in Kolkata. It was during this work that he thought of manufacturing his own drugs instead of selling products made by others.

In 1982, the 27-year-old Shanghvi finally opened his first manufacturing unit with a capital of INR 10,000. He named his venture Sun Pharmaceutical Industries. The unit, located in Vapi in his native state of Gujarat, a short drive away from Mumbai, produced exactly one psychiatry drug. However, the business soon picked up, thanks to Shanghvi's acumen and energy, and by 1997, Sun Pharma was even able to acquire Caraco Pharma, an American company. Sun also acquired Israel's Taro Pharma in 2007. Shanghvi stepped down as chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva Pharmaceuticals, as his successor; Shanghvi became managing director. In April 2014 Sun, Ranbaxy, and Daiichi Sankyo (the majority shareholder in Ranbaxy) agreed that Sun would acquire all outstanding shares of Ranbaxy for $3.2 billion in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and fifth largest in the world, and made Daiichi the second-largest shareholder in Sun.

Source